{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:26:40Z","timestamp":1759483600273},"reference-count":19,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,6,21]],"date-time":"2005-06-21T00:00:00Z","timestamp":1119312000000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ther Apher Dial"],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Immunoadsorption is an adsorption technique for extracorporeal removal of circulating autoantibodies in autoimmune diseases. To prevent microbial growth during storage, the protein A columns are primed with thiomersal, which contains toxic ethyl mercury, which may be released during the procedure and potentially begin to accumulate and become toxic. To reduce the thiomersal\u2010related mercury release during immunoadsorption treatment, we introduced a modified rinsing solution containing N\u2010acetylcysteine, which is an avid mercury scavenger. Thirteen patients received 17 protein A immunoadsorption treatments and their venous blood samples were collected immediately before and after each session. The total blood mercury levels were measured by atomic absorption spectrometry, and the ethyl mercury levels by atomic fluorescence spectrometry. Following the manufacturer's recommendations, we used 600\u2003mg of N\u2010acetylcysteine to rinse the mercury from protein\u2010loaded columns before each immunoadsorption treatment. After immunoadsorption, the ethyl mercury levels increased from 0.148\u2003\u00b1\u20030.402\u2003ng\/g to 2.026\u2003\u00b1\u20031.944\u2003ng\/g (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001), and the total blood mercury levels increased from 2.447\u2003\u00b1\u20033.065\u2003ng\/g to 20.437\u2003\u00b1\u200328.603\u2003ng\/g (<jats:italic>P<\/jats:italic>\u2003=\u20030.02). The post\u2010treatment values of total blood mercury exceeded the upper safety level of 5\u2003ng\/g in all 17 immunoadsorption treatments, but no patient developed clinical signs of mercury toxicity. The results of our study showed an increase in total blood mercury and ethyl mercury levels during the immunoadsorption treatments, suggesting mercury release from thiomersal\u2010primed columns despite the addition of N\u2010acetylcysteine to the rinsing solution.<\/jats:p>","DOI":"10.1111\/j.1774-9987.2005.00266.x","type":"journal-article","created":{"date-parts":[[2005,6,21]],"date-time":"2005-06-21T17:12:47Z","timestamp":1119373967000},"page":"254-257","source":"Crossref","is-referenced-by-count":5,"title":["Increased Ethyl Mercury Load in Protein A Immunoadsorption"],"prefix":"10.1111","volume":"9","author":[{"given":"Andreja","family":"Marn\u2010Pernat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jadranka","family":"Buturovi\u0107\u2010Ponikvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Logar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Horvat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Ponikvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,6,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.10023"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.3.399"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/6.8.536"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(01)02449-6"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.8.2013"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199401063300102"},{"key":"e_1_2_6_8_2","unstructured":"A description of an immunoadsorbent protein A column can be found athttp:\/\/fresenius.com\/product\/immuno_specs.html. Accessed June16 2003."},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg554"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-2670(00)80743-6"},{"key":"e_1_2_6_11_2","first-page":"1976","article-title":"Determination of ethyl mercury and methyl mercury in blood samples","volume":"51","author":"Logar M","year":"2004","journal-title":"RMZ-Mater Geoenviron"},{"key":"e_1_2_6_12_2","first-page":"1","article-title":"Joint statement of the American Academy of Family Physicians (AAFP), the American Academy of Pediatrics (AAP), the Advisory Committee on Immunization Practices (ACIP), and the US Public Health Service (PHS) on Thiomersal in Childhood Vaccines.","volume":"16","author":"AAFP, AAP, ACIP & USPHS.","year":"2000","journal-title":"AAP News"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11682-5"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.11.017"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(84)81021-5"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(80)80159-4"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90061-6"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563659609013818"},{"key":"e_1_2_6_19_2","first-page":"153","article-title":"Neurotoxic character of thiomersal and the allometric extrapolation of adult clearance half\u2010time to infants","volume":"97","author":"Magos L.","year":"2003","journal-title":"J Appl Toxicol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.2307\/3434014"}],"container-title":["Therapeutic Apheresis and Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1774-9987.2005.00266.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1774-9987.2005.00266.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T20:11:53Z","timestamp":1697055113000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1774-9987.2005.00266.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1111\/j.1774-9987.2005.00266.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1774-9987.2005.00266.x","archive":["Portico"],"relation":{},"ISSN":["1744-9979","1744-9987"],"issn-type":[{"value":"1744-9979","type":"print"},{"value":"1744-9987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}